The Trump administration's Department of Justice issued a final order on April 23, 2026, rescheduling FDA-approved marijuana products and state-licensed medical cannabis from Schedule I to Schedule III under the Controlled Substances Act, effectively easing federal tax restrictions via Section 280E for qualifying operators while terminating prior Biden-era proceedings. This action, prompted by President Trump's December 2025 executive order to expedite rescheduling, sets an expedited DEA administrative hearing for June 29, 2026, to evaluate broader cannabis rescheduling amid ongoing lawsuits from prohibitionist groups challenging the order. Traders monitor the hearing outcome, potential appeals, and agency actions, as full descheduling or recreational impacts hinge on these procedural developments.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於$758,300 交易量
6月30日
3%
12月31日
25%
$758,300 交易量
6月30日
3%
12月31日
25%
The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
市場開放時間: Feb 7, 2026, 5:04 PM ET
Resolver
0x65070BE91...The primary resolution source for this market will be official information from the US government, however a consensus of credible reporting will also be used.
Resolver
0x65070BE91...The Trump administration's Department of Justice issued a final order on April 23, 2026, rescheduling FDA-approved marijuana products and state-licensed medical cannabis from Schedule I to Schedule III under the Controlled Substances Act, effectively easing federal tax restrictions via Section 280E for qualifying operators while terminating prior Biden-era proceedings. This action, prompted by President Trump's December 2025 executive order to expedite rescheduling, sets an expedited DEA administrative hearing for June 29, 2026, to evaluate broader cannabis rescheduling amid ongoing lawsuits from prohibitionist groups challenging the order. Traders monitor the hearing outcome, potential appeals, and agency actions, as full descheduling or recreational impacts hinge on these procedural developments.
基於Polymarket數據的AI實驗性摘要。這不是交易建議,也不影響該市場的結算方式。 · 更新於
警惕外部連結哦。
警惕外部連結哦。
Frequently Asked Questions